Asio Capital LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Asio Capital LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,751 shares of the healthcare conglomerate’s stock after selling 170 shares during the period. UnitedHealth Group comprises approximately 1.4% of Asio Capital LLC’s portfolio, making the stock its 20th biggest holding. Asio Capital LLC’s holdings in UnitedHealth Group were worth $7,462,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Dark Forest Capital Management LP grew its stake in UnitedHealth Group by 76.9% in the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after buying an additional 319 shares in the last quarter. Scientech Research LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at $1,071,000. Sepio Capital LP boosted its stake in UnitedHealth Group by 0.3% in the 2nd quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after purchasing an additional 20 shares during the period. Texas Capital Bank Wealth Management Services Inc increased its position in shares of UnitedHealth Group by 6.6% during the second quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock valued at $8,216,000 after buying an additional 994 shares during the period. Finally, Kathmere Capital Management LLC boosted its position in shares of UnitedHealth Group by 25.1% in the second quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock valued at $2,428,000 after acquiring an additional 958 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $532.26 on Friday. The firm has a market cap of $489.83 billion, a PE ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The company’s fifty day simple moving average is $541.04 and its two-hundred day simple moving average is $563.84. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.83 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.58%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on UNH. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.